Seegene

Seegene

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Seegene is a leading molecular diagnostics company that has built a comprehensive ecosystem around PCR technology over its 25-year history. Its core offerings include the Allplex™ high-multiplex assay platform, the CURECA™ automated workflow system, and the STAgora™ cloud-based data intelligence platform. The company is pursuing a unique Technology-Sharing Initiative to expand global access to its proprietary technologies through strategic partnerships. With a presence in over 100 countries, Seegene aims to leverage automation and real-time data to transform global healthcare diagnostics.

Infectious Diseases

Technology Platform

Integrated ecosystem comprising: 1) Allplex™ high-multiplex real-time PCR assay technology, 2) CURECA™ automated modular diagnostic system, and 3) STAgora™ cloud-based data intelligence and surveillance platform.

Funding History

1
IPOUndisclosed

Opportunities

The growing demand for lab automation and syndromic testing presents a major opportunity for Seegene's integrated ecosystem.
Its Technology-Sharing Initiative offers a unique path to rapid global expansion and decentralized assay development for diverse diseases.

Risk Factors

Key risks include intense competition in the molecular diagnostics market, execution challenges in managing the global Technology-Sharing Initiative partnerships, and regulatory hurdles across numerous geographic markets.

Competitive Landscape

Seegene competes in the crowded molecular diagnostics market against large, diversified players like Roche, Abbott, and Thermo Fisher, as well as other MDx specialists. Its differentiation lies in its high-multiplex PCR assays, full-stack automation, and unique technology-sharing partnership model.